Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
33,56 USD | +3,36% | +3,55% | +55,95% |
26/03 | SPYRE THERAPEUTICS, INC. : Stifel Nicolaus ontvangt een koopadvies | ZM |
01/03 | SPYRE THERAPEUTICS, INC. : Wells Fargo Securities positief over het aandeel | ZM |
Omzet 2024 * | 6,82 mln. 6,38 mln. | Omzet 2025 * | 5,17 mln. 4,83 mln. | Marktkapitalisatie | 1,35 mld. 1,26 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -169 mln. -158 mln. | Nettowinst (verlies) 2025 * | -167 mln. -156 mln. | EV/omzet 2024 * | 105 x |
Nettoliquiditeiten 2024 * | 638 mln. 596 mln. | Nettoliquiditeiten 2025 * | 333 mln. 312 mln. | EV/omzet 2025 * | 197 x |
K/w-verhouding 2024 * |
-9,53
x | K/w-verhouding 2025 * |
-11,6
x | Werknemers | 30 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 87,42% |
Recentste transcriptie over Spyre Therapeutics, Inc.
1 dag | +3,36% | ||
1 week | +3,55% | ||
Lopende maand | -11,52% | ||
1 maand | -9,30% | ||
3 maanden | +22,04% | ||
6 maanden | +214,82% | ||
Lopend jaar | +55,95% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Cameron Turtle
CEO | Chief Executive Officer | 34 | 22-06-23 |
Scott Burrows
DFI | Director of Finance/CFO | 47 | 01-09-23 |
Brian Connolly
CTO | Chief Tech/Sci/R&D Officer | - | 27/11 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Tomas Kiselak
BRD | Director/Board Member | 38 | 22-06-23 |
Russell Cox
CHM | Chairman | 60 | 01-06-15 |
Jeffrey Albers
BRD | Director/Board Member | 52 | 27/11 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 33,56 | +3,36% | 225 967 |
25-04-24 | 32,47 | -1,58% | 233 608 |
24-04-24 | 32,99 | -3,68% | 203 860 |
23-04-24 | 34,25 | +2,87% | 201 520 |
22-04-24 | 33,3 | +2,73% | 261 723 |
uitgestelde koers Nasdaq, 26 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+55,95% | 1,35 mld. | |
-2,31% | 103 mld. | |
+0,56% | 95,28 mld. | |
+1,69% | 22,15 mld. | |
-17,37% | 21,02 mld. | |
-9,30% | 18,15 mld. | |
-41,01% | 16,73 mld. | |
-14,85% | 16,05 mld. | |
+3,21% | 13,68 mld. | |
+33,54% | 12,17 mld. |